Vaccines: upcoming dates

Recent

• Health09/30/2026@ThePinGang

  FDA Vaccine Advisers Meet on 2027 Southern Hemisphere Flu Strains

  FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United StatesU.S. Food and Drug Administration

  

  Starts 10/01/2026 1:00PM UTCSCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins75% CONFIDENCEOverall confidence: 75%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better4 days agoFDA's^[1][2] meeting notice lists October 1, 2026, 9:00 a.m. - 1:00 p.m. ET and says the Committee "will convene in open session to discuss strain selection for influenza virus vaccines for the 2027 Southern Hemisphere influenza season".

  FDA's Vaccines and Related Biological Products Advisory Committee meets virtually, 9:00 a.m. to 1:00 p.m. ET, to recommend influenza strains for the 2027 Southern Hemisphere vaccines, with a public FDA webcast.

  20
• Health09/23/2026@HealthDesk

  Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing

  430 Dirksen Senate Office Building, Washington, D.C.U.S. Food and Drug Administration

  

  Starts 09/24/2026 2:30PM UTCSCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins85% CONFIDENCEOverall confidence: 85%How well the pin's source and references back up its dates.Weighted average of how firmly 6 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better11 days agoGiven as scheduled, per help.senate.gov^[1][3]: "Date: Thursday, September 24, 2026 / Time: 10:30 AM ET/ 9:30 AM CT / Location: 430 Dirksen Senate Office Building"; it takes place "directly after the HELP Committee votes" on other nominations, so it may start a little later.

  The Senate HELP Committee questions Dr. Heidi Overton, President Trump's pick for FDA commissioner, at 10:30 a.m. ET in 430 Dirksen. If confirmed, the White House domestic policy aide would take over an agency that has lost more than 3,000 staff in the past year.

  60
• Business10/04/2026@EconDesk

  Sanofi Q2 2026: Sales Up 17.8%, Dupixent Tops EUR 5 Billion, Guidance Raised

  46-48 Avenue de la Grande Armée, Paris, FranceSanofi

  

  Starts 07/30/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins87% CONFIDENCEOverall confidence: 87%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better67 days agoSanofi's^[1] results release is dated July 30, 2026, as is the Pharmaletter^[3] report of the guidance upgrade.

  On 30 July 2026 Sanofi reported second-quarter sales up 17.8% at constant rates to EUR 11.6 billion and business EPS of EUR 2.09, and raised its 2026 outlook to about 10% sales growth.

  00
• Business10/04/2026@HealthDesk

  Sanofi Completes Its US$2.2 Billion Purchase of Dynavax

  46-48 Avenue de la Grande Armée, Paris, FranceSanofi

  

  Starts 02/10/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins86% CONFIDENCEOverall confidence: 86%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better237 days agoSanofi's^[1] press release is dated February 10, 2026 and says it accepted tendered shares for payment and completed the merger that day, after the tender offer expired on 9 February.

  On 10 February 2026 Sanofi completed the acquisition of vaccine maker Dynavax at US$15.50 a share in cash, adding the two-dose hepatitis B vaccine Heplisav-B and a shingles vaccine candidate.

  $2.2B

  00